Alvotech (ICE:ALVO)
Iceland · Delayed Price · Currency is ISK 614.00
-6.00 (-0.97%)
At close: Feb 10, 2026
Alvotech Employees
Alvotech had 1,012 employees as of December 31, 2024. The number of employees increased by 13 or 1.30% compared to the previous year.
Employees
1,012
Change (1Y)
13
Growth (1Y)
1.30%
Revenue / Employee
68.80M ISK
Profits / Employee
8.34M ISK
Market Cap
198.25B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Hagar | 3,508 |
| Hampiðjan | 2,700 |
| Festi | 1,686 |
| Arion banki | 891 |
| Íslandsbanki | 778 |
| Brim hf. | 661 |
| Sildarvinnslan Hf. | 603 |
| Kvika banki | 246 |
Alvotech News
- 1 day ago - ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewsWire
- 2 days ago - Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO - PRNewsWire
- 5 days ago - ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewsWire
- 6 days ago - Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio® - GlobeNewsWire
- 6 days ago - ROSEN, A LEADING NATIONAL FIRM, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO - Newsfile Corp
- 7 days ago - ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO - Newsfile Corp
- 8 days ago - ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewsWire
- 9 days ago - Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates - GlobeNewsWire